Sources | Names Used |
---|---|
CTRPv2 | tanespimycin:gemcitabine (1:1 mol/mol) |
PharmacoGx | tanespimycin:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CPSF6 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
mRNA | MDM4 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-13 |
mRNA | PROSER1 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-13 |
mRNA | ANGEL2 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-13 |
mRNA | SRSF7 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
mRNA | HMGB1 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
mRNA | TMPO | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-12 |
mRNA | HNRNPA1L2 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-12 |
mRNA | LMNB1 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-12 |